Skip to main content

Advertisement

Log in

Embolization treatment of cerebral arteriovenous malformations and amyotrophic lateral sclerosis

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Valavanis A, Schwarz U, Baumann CR, Weller M, Linnebank M (2014) Amyotrophic lateral sclerosis after embolization of cerebral arterioveneous malformations. J Neurol 261:732–737

    Article  CAS  PubMed  Google Scholar 

  2. Lambrechts D, Storkebaum E, Morimoto M et al (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34:383–394

    Article  CAS  PubMed  Google Scholar 

  3. Tovar-Y-Romo LB, Ramírez-Jarquín UN, Lazo-Gómez R, Tapia R (2014) Trophic factors as modulators of motor neuron physiology and survival: implications for ALS therapy. Front Cell Neurosci 28:61

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ourania Katsavarou.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Katsavarou, O., Ntampos, S., Sarmas, I. et al. Embolization treatment of cerebral arteriovenous malformations and amyotrophic lateral sclerosis. Neurol Sci 36, 483–484 (2015). https://doi.org/10.1007/s10072-014-1977-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-014-1977-0

Keywords

Navigation